<DOC>
	<DOC>NCT01094483</DOC>
	<brief_summary>The primary hypothesis of this study is that concomitant multiple-dose administration of PN 400 does not interfere with the platelet inhibitory effects of enteric-coated low-dose aspirin (81 mg), as measured by serum thromboxane B2 inhibition.</brief_summary>
	<brief_title>A Study Assessing Inhibition of Serum Thromboxane B2 Levels With PN400 and Low Dose Aspirin</brief_title>
	<detailed_description />
	<mesh_term>Aspirin</mesh_term>
	<criteria>Stable without clinically significant disease Use of NSAID within 2 weeks Type 1 or 2 DM GI disorder</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Thromboxane B2</keyword>
</DOC>